"Can someone shed light on potential long term targets if we get FDA approval for TBI and Concussion as well?"
So TBI and concussion as well as Retts. (but not fragile X) long term:
$60 billion.
But if Retts and fragile X are both successful, then there's a likelihood of having a treatment for autism. Then the numbers get really big.
Surely a large pharmaceutical company will push a deal or takeover soon. Roche are very keen on fragile X and neural disorders.
buy and hold
Long term price target, page-20
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.14 |
Change
1.150(5.48%) |
Mkt cap ! $2.829B | |||
| Open | High | Low | Value | Volume |
| $21.50 | $22.44 | $21.50 | $13.15M | 598.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 437 | $22.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.15 | 8325 | 7 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |